Expression of coxsackie and adenovirus receptor in small cell lung cancer

Chinese-German Journal of Clinical Oncology

Volumn 8, Issue 9, 2009, Pages 504-505

  Bao, Yongyi ^a   Wang, Yong ^a   Ma, Lingdi ^a   Guan, Naifu ^a   Cheng, Yuqing ^a   Wang, Shizhong ^a   Fan, Xiaolong ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Coxsackie and adenovirus receptor; Genetherapy; Immunohistochemistry; Small cell lung cancer

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; FORMALDEHYDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; MALE;

EID: 70349311701     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-009-0128-1     Document Type: Article

References (5)

1. Toloza EM. Gene therapy for lung cancer. Thorac Surg Clin, 2006, 16: 397-419.
2. Qin M, Chen S, Yu T, et al. Coxsackievirus adenovirus receptor expression redictsthe efficiency of adenoviral gene transfer into non-small cell lung canaer xenografts. Clin Cancer Res, 2003, 9:4992-4999.
3. Li Y, Pong RC, Bergelson JM, et al. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy. Cancer Res, 1999, 59: 325-330.
4. Douglas JT, Kim M, Sumerel LA, et al. Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary adreceptors. Cancer Res, 2001, 61: 813-817.
5. Wang Y, Wang S, Bao Y, et al. Coxsackievirus and adenovirus receptor expression in non-malignant lung tissues and clinical lung cancers. J Mol Histol, 2006, 37: 153-160.